Back

Edoxaban in dialysis: a 4-year follow-up in a single center experience

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Arrhythmia treatment update Prevention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Giovanni Fazio

Polimedic, Palermo (Italy)

Access the full session

Session thumbnail
Arrhythmia treatment update

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Anticoagulation patterns in haemodialysis patients - how do we anticoagulate in the absence of indications?
thumbnail
Congress Presentation
Long-term real-world outcomes of edoxaban in atrial fibrillation patients with and without prior ischaemic stroke: A 4-year follow-up analysis from ETNA-AF Europe

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources